Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02830542
Recruitment Status : Unknown
Verified March 2018 by Seres Therapeutics, Inc..
Recruitment status was:  Active, not recruiting
First Posted : July 13, 2016
Last Update Posted : April 20, 2018
Sponsor:
Collaborator:
Pharm-Olam International
Information provided by (Responsible Party):
Seres Therapeutics, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : June 2018
Estimated Study Completion Date : October 2018